Search results

  1. K

    How do repos introduce leverage?

    This helps very much, thank you David!
  2. K

    How do repos introduce leverage?

    Hi @David Harper CFA FRM , thank you for the explanation - this seems to really clear things up. The concept I'm hung up on is that if a hedge fund has securities to use as collateral in a repo (for example, treasuries), why not just sell those, get the cash, and use that to fund the purchase...
  3. K

    How do repos introduce leverage?

    I have heard that repos can be used to gain leverage, particularly within hedge funds. However, if repo sellers (who borrow cash) have to post collateral, and the value of collateral is reduced via a haircut, wouldn't this in effect be the opposite of leverage? i.e. repo sellers would be getting...
  4. K

    Inconsistent test-statistic formula between Jorion (Market Risk) and Bodie (Investments)

    very helpful. Thank you for the quick reply and explantion!
  5. K

    Course Errors Found in 2021/2022 Study Materials P2.T6. Credit Risk

    In Gregory, P.74, on the difficult CVA calculation, at the bottom: In first year, mPD is same as PD at 9.52%, in 2nd year, mPD = 18.1% -9.5% =9.52%, Should read: In first year, mPD is same as PD at 9.52%, in 2nd year, mPD = 18.1% -9.5% =8.61%,
  6. K

    Inconsistent test-statistic formula between Jorion (Market Risk) and Bodie (Investments)

    Why is it that the test stat for VaR backtesting (Jorion) equals the sample estimate minus the population estimate divided by the standard error, while in Bodie, it equals the sample estimate times (n^.5) divided by the standard error? In other words - Jorion: (actual exceptions - expected...
  7. K

    Clarifying question on "a" and "r" in lognormal model - tuckman

    Hi, within Tuckman's lognormal model, dr = a r dr + (vol) r dw. To clarify, is a equivalent to lambda (drift) and r equivalent to r(0), that is, the initial rate? I am struggling a bit between the initial formula for the lognormal model (Tuckman 10.5) and the formula which we'd likely use on...
  8. K

    Course Study Plan Guide

    Hi all, I'm trying to best determine what my approach should be for studying. I've done the following, in this order: Finish the readings, and take notes Re-read, but this time taking notes and making notecards for each LOB Do all the global topic reviews Finish all the practice questions At...
  9. K

    Inconsistencies in marginal var formula - Jorion Ch7

    Think I may have answered my own question by forgetting that beta has variance of the portfolio in the denominator, rather than std dev
  10. K

    Inconsistencies in marginal var formula - Jorion Ch7

    In the formula sheet for Marginal Var, it states that marginal var = deviate * Covariance(asset, portfolio)/(std. dev. of portfolio) It also states that marginal var = deviate * Beta(asset, portfolio) * (std. dev. of portfolio). Given that Beta(asset, portfolio) = Covariance(asset...
  11. K

    Inconsistency in Stulz's BSM Equity Formula

    In the study notes for Stulz, the BSM equity price formula's D1 term is (ln(value of assets/face value) + (r + (variance of asset returns)/2) * T) / (std dev asset returns) * T^.5 However, in the attached spreadsheet, the BSM formula is closer to what we're used to seeing: (ln(value of...
  12. K

    Course (Archived thread) Errors Found in 2021/2022 Study Materials P2.T7. Operational & Integrated Risk

    In "Describe the motivations for and calculate the capital conservation buffer and the countercyclical buffer introduced in Basel III, including special rules for globally systemically important banks (G-SIBs)." Within T7-R37-P2-Carey (appx. P.10), the notes state: total tier 1 capital equals...
  13. K

    Course Errors Found in 2021/2022 Study Materials P2.T6. Credit Risk

    In Gregory, chapter 11, under the objective: Explain how payment frequencies and exercise dates affect the exposure profile of various securities, the wording is contradictory. "If payments are made more frequently than received, then the exposure is reduced. On the other hand, if payments...
  14. K

    PART II - help with explaining the costs of an OTC derivative - Gregory, Ch 3.

    In Gregory, Ch, 3, under the LOB Identify & explain the costs of an OTC derivative, Gregory seems to make some counterintuitive points. (page 10/11 in the study notes) At the onset, I would imagine that a bank would hedge an OTC derivative with a hedge that would pay out when the bank has a...
  15. K

    Course Errors Found in 2021/2022 Study Materials P2.T6. Credit Risk

    Hey @Nicole Seaman thanks for the quick reply. Most of the bookmark errors I found are on page 9 of the pdf. There's also a separate, additional error where the equation on p. 15 is missing a leading N(), in that the parentheses aren't wrapped by the cumulative standard normal operator. With...
  16. K

    Course Errors Found in 2021/2022 Study Materials P2.T6. Credit Risk

    When reviewing the study notes for DeLaurentis, it seems like there are a lot of errors. What is the general advice for this section - should we still memorize the formulas, or just know the difference between the general default terms in the reading? Also, what does "Error! Bookmark not...
  17. K

    testability by topic?

    Got it. Thanks, David!
  18. K

    testability by topic?

    I saw that in some seemingly older videos, David includes a score of testability per topic. Is this statistic still prepared/shared for 2021 exams somewhere? Would it be possible to see a review of which topics might be the most "testable"?
Top